News|Articles|March 4, 2024

Pharma Pulse 3/4/24: Local Pharmacies on the Brink, People in MA Plans Experienced Delays in Accessing Care & more

The latest news for pharma industry insiders.

Cencora's Corey Ford Discusses the Future of the Inflation Reduction Act

In an interview with Associate Editor Don Tracy, Corey Ford, VP, Reimbursement & Policy Insights, Cencora, offers his thoughts on where the Inflation Reduction Act will be five to 10 years from now.

Survey Finds People in MA Plans Experienced Delays in Accessing Care

The Commonwealth Fund 2024 Value of Medicare Survey surveyed 3,280 Medicare beneficiaries about access to benefits, services, providers, care coordination, and satisfaction. The survey was conducted by SSRS for the Commonwealth Fund between Nov. 6, 2023, and Jan. 4, 2024 and found about two thirds of older Americans enrolled in Medicare Advantage or traditional plans say their coverage met expectations

This RSV Shot Keeps Babies Out of the Hospital. But Parents Can’t Find It.

A new antibody that protects babies from a deadly virus proved far more popular than drugmaker Sanofi expected

Local Pharmacies on the Brink, New Survey Reveals

As rumors swirl in Washington, D.C., that lawmakers may once again be punting on PBM reform, the National Community Pharmacists Association recently released a survey showing many local pharmacies are running out of time.

From @IQVIA_Institute on X:

Originally sanctioned for diabetes management as Ozempic, semaglutide's pivot toward weight loss promotion as Wegovy resulted in a surge in purchases and increased the IOP market share. Read more in IQVIA Institute’s report: https://bit.ly/49Rar0j. #Pharma

Have news you want us to share in Pharma Pulse? Reach out to Social Media Editor Miranda Schmalfuhs.


Related to this article

Silver Spring, MD, USA - June 25, 2022: The FDA White Oak Campus, headquarters of the United States Food and Drug Administration, a federal agency of the Department of Health and Human Services (HHS). | © Tada Images - stock.adobe.com 521699065
In this week’s Pharma Pulse, the FDA launches a program that lets companies share its approval packages with foreign regulators, UPS agrees to acquire Australia and New Zealand health care courier Smartways Logistics and Cognizant introduces an AI-enabled patient hub offering.
CVS Pharmacy Sign at Storefront Entrance | © Mark Roger Bailey - stock.adobe.com 557616813
In this week’s Pharma Pulse, CVS Health plans to separate into two public companies, Bayer weighs what MFN pricing could mean for its launch strategies and an ACTO survey finds most life sciences leaders see no clear industry standard for responsible AI.